MacKay-Dunn R. Hector

Track

Insider profile

MacKay-Dunn R. Hector's trades of Aurinia Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
11.00
Quantity 5,000 +83.3%
Value US$54,985
Transaction date
Purchase
Price
11.28
Quantity 1,600 +36.4%
Value US$18,040
Transaction date
Purchase
Price
11.26
Quantity 1,400 +46.7%
Value US$15,764
Transaction date
Purchase
Price
11.14
Quantity 1,000 +50.0%
Value US$11,140
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-05-22 2024-05-21
S Sale
12,547 +8.0%
248.44
US$308,710 		12,547 +8.0% 248.44 US$308,710
2024-05-22 2024-05-21
S Sale
48,572 +47.8%
392.17
US$367,905 		48,572 +47.8% 392.17 US$367,905
2023-05-23 2023-05-23
S Sale
43,861 +28.3%
116.96
US$3,912,288 		43,861 +28.3% 116.96 US$3,912,288
2022-03-11 2022-03-09
B Purchase
5,000 +83.3%
11.00
US$54,985 		5,000 +83.3% 11.00 US$54,985
2021-05-13 2021-05-12
B Purchase
1,600 +36.4%
11.28
US$18,040 		1,600 +36.4% 11.28 US$18,040
2021-05-13 2021-05-12
B Purchase
1,400 +46.7%
11.26
US$15,764 		1,400 +46.7% 11.26 US$15,764
2021-05-13 2021-05-11
B Purchase
1,000 +50.0%
11.14
US$11,140 		1,000 +50.0% 11.14 US$11,140
2021-05-13 2021-05-11
B Purchase
500 +33.3%
11.17
US$5,585 		500 +33.3% 11.17 US$5,585